Alnylam Pharmaceuticals, Inc. v. Cipla USA Inc. et al
Plaintiff: Alnylam Pharmaceuticals, Inc.
Defendant: Cipla USA Inc. and Cipla Ltd.
Case Number: 1:2026cv01166
Filed: September 16, 2026
Court: U.S. District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 28 U.S.C. ยง 2201 Constitutionality of State Statute(s)
Jury Demanded By: None
Docket Report

This docket was last retrieved on September 17, 2026. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 17, 2026 Filing 6 Summons Issued as to Cipla Ltd. on 9/17/2026; Cipla USA Inc. on 9/17/2026. (Attachments: #1 Summons Issued)(jaa)
September 16, 2026 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Fidelity Management & Research Company LLC for Alnylam Pharmaceuticals, Inc. filed by Alnylam Pharmaceuticals, Inc. (jaa)
September 16, 2026 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,612,024; 10,208,307; 10,683,501; 11,286,486; 12,049,628. (jaa)
September 16, 2026 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 3, 2026. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: 12/13/2029. (jaa)
September 16, 2026 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jaa)
September 16, 2026 Filing 1 COMPLAINT against Cipla Ltd., Cipla USA Inc. (Filing fee $ 405, receipt number ADEDC-5067249) - filed by Alnylam Pharmaceuticals, Inc. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet)(jaa)

Access additional case information on PACER

Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Alnylam Pharmaceuticals, Inc. v. Cipla USA Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Alnylam Pharmaceuticals, Inc.
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla USA Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?